Differential effects of neuroleptic agents on hepatic cytochrome P-450 isozymes in the male rat

Biochimica et Biophysica Acta - General Subjects

Volumn 1291, Issue 1, 1996, Pages 60-66

  Rane, Anders ^a   Liu, Zhurong ^a   Levol, Robert ^a   Bjelfman, Catarina ^a   Thyr, Charlotte ^a   Ericson, Hans ^a   Hansson, Tiiu ^b   Henderson, Colin ^c   Wolf, C Roland ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Astra Arcus AB   (Sweden)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cytochrome P 450; Hepatic regulation; mRNA; Neuroleptic; Rat liver

Indexed keywords

ANDROSTENEDIONE; CLOZAPINE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; MESSENGER RNA; NEUROLEPTIC AGENT; REMOXIPRIDE; SULPIRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOBLOTTING; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEROID METABOLISM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030605954     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-4165(96)00046-3     Document Type: Article

References (37)

1. [1] Gonzalez, F.J. (1988) Pharmacol. Rev. 40, 243-288.
2. [2] Zaphiropoulos, P.G., Mode, A., Norstedt, G. and Gustafsson, J.-Å. (1989) Trends Pharmacol. Sci. 10, 149-153.
3. [3] Mode, A., Gustafsson, J.-Å., Jansson, J.-O., Edén, S. and Isaksson, O. (1982) Endocrinology 111, 1692-1697.
4. [4] Waxman, D.J., Ram, P.A., Notani, G., Le Blanck, G.A., Alberta, J.A., Morrissey, J.J. and Sundseth, S.S. (1990) Mol. Endocrinol. 4, 447-454.
5. [5] Blanck, A., Åström, A. and Hansson, T. (1986) Cancer Res. 46, 5072-5076.
6. [6] Blanck, A., Hansson, T., Assefaw-Redda, Y. and Rane, A. (1990) Biochem. Pharmacol. 40, 2177-2180.
7. [7] Blanck, A., Hansson, T., Näslund, B. and Rane, A. (1990) Biochem. Pharmacol. 39, 1820-1822.
8. [8] Rane, A. and Ask, B. (1992) J. Steroid. Biochem. Mol. Biol. 41, 91-98.
9. [9] Rane, A., Liu, Z., Henderson, C. and Wolf, C.R. (1995) Mol. Pharmacol. 47, 57-64.
10. [10] Rane, A., Bjelfman, C., Thyr, C. and Porsch Hällström, I. (1994) Regul. Peptides Suppl. 1, S273-S278.
11. [11] Mueller, G.P., Simpkins, J., Meites, J. and Moore, K.E. (1976) Neuroendocrinology 20, 121-135.
12. [12] Kato, Y., Dupre, J. and Beck, J.C. (1973) Endocrinology 93, 135.
13. [13] Ström, A., Eguchi, H., Mode, A., Legraverend, C., Tollet, P., Strömstedt, P.E. and Gustafsson, J.-Å. (1994) DNA Cell. Biol. 13, 805-819.
14. [14] Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156-159.
15. [15] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) J. Biol. Chem. 193, 265-275.
16. [16] Ladona, M.G., Spalding, D.J.M., Ekman, L., Lindström, B. and Rane, A. (1989) Biochem. Pharmacol. 38, 3147-3155.
17. [17] Taylor, R.B., Kendle, K.E., Reid, R.G. and Hung, C.T. (1987) J. Chromatogr. 385, 383-392.
18. [18] Forrester, L.M., Henderson, C.J., Glancey, M.J., Back. D.J., Park, B.K., Ball, S.E., Kitteringham, N.R., McLaren, A.W., Miles, J.S., Skett, P. and Wolf, C.R. (1992) Biochem. J. 281, 359-368.
19. [19] Durnam, D.M. and Palmiter, R.D. (1983) Anal. Biochem. 131, 388-393.
20. [20] Melton, D.A., Krieg, P.A., RebagliatL M.R., Maniatis, T., Zinn, K. and Green, M.P. (1984) Nucleic Acids Res. 12, 7035-7056.
21. [21] Blanck, A., Porsch Hällström, I.P., Svensson, D., Mode, A., Eriksson, L.C. and Gustafsson, J.-Å. (1993) Carcinogenesis 14, 755-759.
22. [22] Yoshioka, H., Morohashi K.-I., Sogawa, K., Miyata, T., Kawajiri, K., Hirose, T., Inayama, S., Fujii-Kuriyama, Y. and Omura, T. (1987) J. Biol. Chem. 262, 1706-1711.
23. [23] Zaphiropoulos, P.G., Mode, A., Ström, A., Möller, C., Fernandez, C. and Gustafsson, J.-Å. (1988) Proc. Natl. Acad. Sci. USA 85, 4214-4217.
24. [24] Seeman, P. (1990) Acta Psychiatr. Scand. 82 Suppl. 385, 14-20.
25. [25] Köhler, C., Hall, H., Ögren, S.-O. and Gawell, L. (1985) Biochem. Pharmacol. 34, 2251-2259.
26. [26] Ogren, S.-O., Florvall, L., Hall, H., Magnusson, O. and Angeby-Möller, K. (1990) Acta Psychiatr. Scand. 82 Suppl. 385, 21-26.
27. [27] Janeczko, R., Waxman, D.J., Le Blanc, G.A., Morville, A. and Adesnik, M. (1990) Mol. Endocrinol. 4, 295-303.
28. [28] Mode, A., Norstedt, G., Simic, B., Eneroth, P. and Gustafsson, J.-Å. (1981) Endocrinology 108, 2103-2108.
29. [29] Guengerich, F.P., Dannan, G.A., Wright, S.T., Martin, M.V. and Kaminsky, L.S. (1982) Biochemistry 21, 6019-6030.
30. [30] Murray, M. (1992) Biochem. Pharmacol 44, 1219-1222.
31. [31] Waxman, D.J., Dannan, G.A. and Guengerich, F.P. (1985) Biochemistry 24, 4409-4417.
32. [32] Miura, T., Iwasaki, M., Komori, M., Ohi, H., Kitada, M., Mitsui, H. and Kamataki, T. (1989) J. Antimicrob. Chemother. 24, 551-559.
33. [33] Pessayre, D., Konstantinova-Mitcheva, M., Descatoire, V., Cobert, J., Wandscheer, J.C., Level, R., Feldman, G., Mansuy, D. and Benhamou, J.P. (1981) Biochem. Pharmacol. 30, 559-564.
34. [34] Morgan, E.T. (1990) Drug Metab. Dispos. Biol. Fate Chem. 18. 649-653.
35. [35] Morgan, E.T. (1991) Biochem. Pharmacol. 24, 51-57.
36. [36] Gram, L.F. (1975) Psychopharmacol. Commun. 1, 165-175.
37. [37] Meltzer, H.Y. (1985) Adv. Biochem. Psychopharmacol. 40, 59-68.